「ca」の検索結果
161件：31～35件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA American Journal of O...
http://www.senju.co.jp/english/rd/thesis/ -
お知らせ | 千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtain...
http://www.senju.co.jp/english/news/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
ent of “a joy to behold” or QOV (Quality of Vision) of patients worldwide. We commercialized senile cataract drugs in 1958, and subsequently, antimicrobial ophthalmic solutions, non-steroidal anti-inf...
http://www.senju.co.jp/english/rd/policy/ -
Quality Policies | About Senju | SENJU Pharmaceutical
ways pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standards on product quality, and exercise...
http://www.senju.co.jp/english/about/quality.html -
Business Activities | About Senju | SENJU Pharmaceutical
y that puts top priority on safety, we have always taken a pioneering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to tak...
http://www.senju.co.jp/english/about/business/